hydroquinone has been researched along with Incontinentia Pigmenti Achromians in 41 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients with exogenous ochronosis, an unfamiliar side effect of hydroquinone-containing bleaching creams, are presented." | 7.68 | [Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments]. ( Dekker, SK; Menke, HE; Noordhoek Hegt, V; Pavel, S; Westerhof, W, 1992) |
| "Two patients with exogenous ochronosis, an unfamiliar side effect of hydroquinone-containing bleaching creams, are presented." | 3.68 | [Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments]. ( Dekker, SK; Menke, HE; Noordhoek Hegt, V; Pavel, S; Westerhof, W, 1992) |
| "Hexylresorcinol is an ingredient that has been used in food preservation and as antiseptic has been shown to inhibit tyrosinase in vitro and has been studied as a novel skin-lightening agent." | 3.30 | Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance. ( Burney, WA; Chambers, CJ; Gabriel, TA; Pan, A; Sivamani, RK; Wu, H, 2023) |
| "Hydroquinone has been the standard prescription agent for skin lightening; however, its use recently has become controversial." | 2.75 | Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. ( Bhushan, P; Draelos, ZD; Oresajo, C; Pillai, S; Yatskayer, M, 2010) |
| "Hyperpigmentation disorders and skin lightening treatments have a significant impact on the dermatologic, physiologic, psychologic, economic, social, and cultural aspects of life." | 2.47 | Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. ( Kundu, RV; Ladizinski, B; Mistry, N, 2011) |
| "Hydroquinone has been marketed in skin-lightening products for almost 50 years and remains as the most frequently used whitening constituent in the category." | 2.46 | Hydroquinone for skin lightening: safety profile, duration of use and when should we stop? ( Tse, TW, 2010) |
| "Treatment of hyperpigmentation disorders can be a lengthy process." | 1.36 | [Methods and means for pigmentation and depigmentation. Sense or nonsense?]. ( Hegyi, J; Hegyi, V, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (31.71) | 18.7374 |
| 1990's | 6 (14.63) | 18.2507 |
| 2000's | 8 (19.51) | 29.6817 |
| 2010's | 13 (31.71) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, H | 2 |
| Gabriel, TA | 2 |
| Burney, WA | 2 |
| Chambers, CJ | 2 |
| Pan, A | 2 |
| Sivamani, RK | 2 |
| Yanagishita-Nakatsuji, S | 1 |
| Fukai, K | 1 |
| Ohyama, A | 1 |
| Umekoji, A | 1 |
| Sowa-Osako, J | 1 |
| Tsuruta, D | 1 |
| Zubair, R | 1 |
| Lyons, AB | 1 |
| Vellaichamy, G | 1 |
| Peacock, A | 1 |
| Hamzavi, I | 1 |
| Draelos, Z | 1 |
| Dahl, A | 1 |
| Yatskayer, M | 3 |
| Chen, N | 2 |
| Krol, Y | 2 |
| Oresajo, C | 3 |
| Kang, SJ | 1 |
| Davis, SA | 1 |
| Feldman, SR | 1 |
| McMichael, AJ | 1 |
| Tatebayashi, M | 1 |
| Oiso, N | 1 |
| Wada, T | 1 |
| Suzuki, K | 1 |
| Matsunaga, K | 1 |
| Kawada, A | 1 |
| Draelos, ZD | 2 |
| Raab, S | 1 |
| ANDERSON, B | 2 |
| COGAN, DG | 1 |
| GRANT, WM | 1 |
| Garg, T | 1 |
| Srihar, R | 1 |
| Gupta, TP | 1 |
| Dadzie, OE | 1 |
| Petit, A | 1 |
| Kang, HY | 1 |
| Valerio, L | 1 |
| Bahadoran, P | 1 |
| Ortonne, JP | 1 |
| Camus, M | 1 |
| Wierzbicka-Hainaut, E | 1 |
| Dammak, A | 1 |
| Fromont, G | 1 |
| Guillet, G | 1 |
| Tse, TW | 1 |
| Zawar, V | 1 |
| Chuh, A | 1 |
| Hegyi, V | 1 |
| Hegyi, J | 1 |
| Bhushan, P | 1 |
| Pillai, S | 1 |
| Ladizinski, B | 1 |
| Mistry, N | 1 |
| Kundu, RV | 1 |
| Mauricio, T | 1 |
| Karmon, Y | 1 |
| Khaiat, A | 1 |
| Mahé, A | 1 |
| Ly, F | 2 |
| Aymard, G | 1 |
| Dangou, JM | 1 |
| KELLY, EW | 1 |
| GARZA TOBA, M | 1 |
| DORSEY, CS | 1 |
| KAMINSKY, A | 1 |
| DAITSCH, J | 1 |
| SIDI, E | 1 |
| BOURGEOIS-SPINASSE, J | 1 |
| PLANAT, P | 1 |
| KALZ, F | 1 |
| SCHOPFLOCHER, P | 1 |
| ZAMITH, VA | 1 |
| Halder, RM | 1 |
| Richards, GM | 1 |
| Soko, AS | 1 |
| Dione, DA | 1 |
| Niang, SO | 1 |
| Kane, A | 1 |
| Bocoum, TI | 1 |
| Dieng, MT | 1 |
| Ndiaye, B | 1 |
| Tan, SK | 1 |
| Sim, CS | 1 |
| Goh, CL | 1 |
| Fisher, AA | 1 |
| Yi, K | 1 |
| Hart, LL | 1 |
| Coulson, IH | 1 |
| Menke, HE | 2 |
| Westerhof, W | 2 |
| Bekhor, PS | 1 |
| Chess, C | 1 |
| Fernandes, D | 1 |
| Dekker, SK | 1 |
| Noordhoek Hegt, V | 1 |
| Pavel, S | 1 |
| Markey, AC | 1 |
| Black, AK | 1 |
| Rycroft, RJ | 1 |
| Boyle, J | 1 |
| Kennedy, CT | 1 |
8 reviews available for hydroquinone and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
What's New in Pigmentary Disorders.
Topics: alpha-MSH; Antifibrinolytic Agents; Bimatoprost; Dermatologic Agents; Humans; Hydroquinones; Inflamm | 2019 |
Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
Topics: Dermatologic Agents; Drug Approval; Female; Humans; Hydroquinones; Male; Pigmentation Disorders; Ski | 2009 |
The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.
Topics: Administration, Cutaneous; Antioxidants; Dermatologic Agents; Drug Therapy, Combination; Evidence-Ba | 2009 |
Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
Topics: Consumer Product Safety; Dermatologic Agents; Humans; Hydroquinones; Melanocytes; Pigmentation Disor | 2010 |
Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
Topics: Administration, Topical; Adrenal Cortex Hormones; Cosmetics; Dermatologic Agents; Humans; Hydroquino | 2011 |
Management of dyschromias in ethnic skin.
Topics: Administration, Cutaneous; Arbutin; Black People; Dicarboxylic Acids; Humans; Hydroquinones; Keratol | 2004 |
Hydroquinone-induced exogenous ochronosis in Chinese--two case reports and a review.
Topics: Administration, Cutaneous; Asian People; Dermatologic Agents; Female; Humans; Hydroquinones; Melanos | 2008 |
The role of pulsed laser in the management of cosmetically significant pigmented lesions.
Topics: Humans; Hydroquinones; Laser Therapy; Pigmentation Disorders; Radiation-Protective Agents | 1995 |
5 trials available for hydroquinone and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance.
Topics: Adult; Double-Blind Method; Female; Hexylresorcinol; Humans; Hydroquinones; Middle Aged; Pigmentatio | 2023 |
Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance.
Topics: Adult; Double-Blind Method; Female; Hexylresorcinol; Humans; Hydroquinones; Middle Aged; Pigmentatio | 2023 |
Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance.
Topics: Adult; Double-Blind Method; Female; Hexylresorcinol; Humans; Hydroquinones; Middle Aged; Pigmentatio | 2023 |
Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance.
Topics: Adult; Double-Blind Method; Female; Hexylresorcinol; Humans; Hydroquinones; Middle Aged; Pigmentatio | 2023 |
Dyspigmentation, skin physiology, and a novel approach to skin lightening.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Drug Combinations; Ellagic Acid; Face; Female | 2013 |
A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
Topics: Adult; Cosmeceuticals; Double-Blind Method; Female; Humans; Hydroquinones; Hyperpigmentation; Kerato | 2015 |
Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
Topics: Administration, Cutaneous; Adult; Antioxidants; Dermatologic Agents; Double-Blind Method; Drug Combi | 2010 |
A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream.
Topics: Administration, Cutaneous; Adult; Antioxidants; Asian People; Dermatologic Agents; Double-Blind Meth | 2011 |
28 other studies available for hydroquinone and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Probable allergic contact dermatitis from hydroquinone presenting as leukomelanoderma: Report of two cases.
Topics: Antioxidants; Dermatitis, Allergic Contact; Diagnosis, Differential; Female; Humans; Hydroquinones; | 2017 |
Dyschromia in skin of color.
Topics: Adolescent; Adrenal Cortex Hormones; Aged; Asian People; Black or African American; Child; Child, Pr | 2014 |
Possible allergic contact dermatitis with reticulate postinflammatory pigmentation caused by hydroquinone.
Topics: Dermatitis, Allergic Contact; Female; Humans; Hydroquinones; Middle Aged; Patch Tests; Pigmentation | 2014 |
Corneal and conjunctival pigmentation among workers engaged in manufacture of hydroquinone.
Topics: Conjunctiva; Conjunctival Diseases; Cornea; Corneal Diseases; Humans; Hydroquinones; Pigmentation; P | 1947 |
Corneal and conjunctival pigmentation among workers in hydroquinone.
Topics: Conjunctiva; Conjunctival Diseases; Cornea; Corneal Diseases; Humans; Hydroquinones; Pigmentation; P | 1947 |
Acquired dermal melanocytosis involving the hand.
Topics: Administration, Cutaneous; Adolescent; Drug Combinations; Hand; Humans; Hydroquinones; Lasers, Solid | 2009 |
Hydroquinone is both effective on pigmentation and lichenoid papules of chronic lichenoid graft-versus-host disease.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Fema | 2010 |
Exogenous ochronosis in Asians.
Topics: Antioxidants; Asian People; Humans; Hydroquinones; Melanosis; Ochronosis; Pigmentation Disorders | 2010 |
[Methods and means for pigmentation and depigmentation. Sense or nonsense?].
Topics: Antioxidants; Humans; Hydroquinones; Pigmentation Disorders | 2010 |
Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Antioxidants; Caustics; Cosmetics; Dermatitis, Contact; Derm | 2003 |
Pigmented skin lesions; treatment with monobenzyl-ether of hydroquinone.
Topics: Ether; Ethers; Humans; Hydroquinones; Phenols; Pigmentation; Pigmentation Disorders | 1956 |
[25 cases of dyschromia caused by hydroquinone].
Topics: Humans; Hydroquinones; Phenols; Pigmentation; Pigmentation Disorders; Skin Diseases | 1961 |
Dermatitic and pigmentary reactions to monobenzyl ether of hydroquinone: report of two cases.
Topics: Dermatitis; Drug Eruptions; Ether; Humans; Hydroquinones; Medical Records; Pigmentation; Pigmentatio | 1960 |
[Dyschromia caused by monobenzylether of hydroquinone].
Topics: Humans; Hydroquinones; Melanins; Phenols; Pigmentation; Pigmentation Disorders; Skin Diseases | 1959 |
[Treatment of hyperpigmentations by hydroquinone derivatives].
Topics: Humans; Hydroquinones; Hyperpigmentation; Pigmentation Disorders; Quinones | 1961 |
[LEUKOMELANODERMA AFTER THE USE OF HYDROQUINONE OINTMENT IN TWINS].
Topics: Chromatophores; Diseases in Twins; Humans; Hydroquinones; Ointments; Phenols; Pigmentation Disorders | 1965 |
[LEUCOMELANODERMA CAUSED BY HYDROQUINONE].
Topics: Colonic Diseases; Humans; Hydroquinones; Melanosis; Phenols; Pigmentation Disorders; Toxicology | 1965 |
Observation on Corneal and Conjunctival Pigmentation Occurring Among Workers Engaged in the Manufacture of Hydroquinone.
Topics: Conjunctiva; Cornea; Corneal Diseases; Humans; Hydroquinones; Industry; Occupations; Pigmentation; P | 1946 |
Aesthetic problems associated with the cosmetic use of bleaching products.
Topics: Administration, Topical; Adolescent; Adult; Atrophy; Cosmetics; Dermatologic Agents; Female; Glucoco | 2007 |
Leukoderma from bleaching creams containing 2% hydroquinone.
Topics: Cosmetics; Humans; Hydroquinones; Pigmentation Disorders | 1982 |
Use of hydroquinone as a bleaching cream.
Topics: Chemistry, Pharmaceutical; Humans; Hydroquinones; Melanosis; Ointments; Pigmentation Disorders | 1993 |
'Fade out' photochromonychia.
Topics: Aged; Female; Humans; Hydroquinones; Middle Aged; Nail Diseases; Ointments; Photosensitivity Disorde | 1993 |
[Minor symptoms in family medicine; chloasma or 'pregnancy mask'].
Topics: Female; Humans; Hydroquinones; Melanosis; Ointments; Pigmentation Disorders; Pregnancy; Radiation-Pr | 1995 |
Nothing like a little science now and then.
Topics: Erythema; Glycolates; Humans; Hydroquinones; Keratolytic Agents; Laser Therapy; Lasers; Pigmentation | 1999 |
Hydroquinone--a harmful agent.
Topics: Antioxidants; Cosmetics; Humans; Hydroquinones; Pigmentation Disorders; South Africa | 2000 |
[Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments].
Topics: Adult; Female; Humans; Hydroquinones; Middle Aged; Ochronosis; Ointments; Pigmentation Disorders; Sk | 1992 |
Confetti-like depigmentation from hydroquinone.
Topics: Cosmetics; Humans; Hydroquinones; Male; Middle Aged; Pigmentation Disorders | 1989 |
Leukoderma from hydroquinone.
Topics: Female; Humans; Hydroquinones; Pigmentation Disorders | 1985 |